# The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)

> **NCT00816907** · PHASE4 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 146 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00816907
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2013-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816907, "The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00816907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*